STOCK TITAN

Aptargroup - ATR STOCK NEWS

Welcome to our dedicated page for Aptargroup news (Ticker: ATR), a resource for investors and traders seeking the latest updates and insights on Aptargroup stock.

AptarGroup, Inc. (ATR) delivers innovative dispensing systems and packaging solutions for pharmaceutical, beauty, and consumer goods markets worldwide. This page provides centralized access to official company announcements, financial updates, and industry developments.

Investors and stakeholders will find timely updates including earnings reports, product innovations, and strategic partnerships. Our curated news collection simplifies tracking regulatory milestones and market trends impacting AptarGroup's core segments: Pharma, Beauty, and Closures.

All content is sourced from verified corporate communications and reputable financial publications. Bookmark this page for efficient monitoring of ATR's operational developments, sustainability initiatives, and leadership changes within the global packaging industry.

Rhea-AI Summary

AptarGroup, Inc. (NYSE: ATR) has been recognized on the CDP Supplier Engagement Leaderboard for the third consecutive year, positioning itself among the top 8% of companies evaluated for climate change engagement. Aptar received an ‘A’ rating, surpassing the North America regional average of ‘C’ and the plastic product manufacturing average of ‘C-‘. The company actively collaborates with suppliers to reduce emissions, focusing on the significant scope 3 emissions from purchased goods, particularly plastics. Additionally, Aptar aims to enhance its supply chain diversity through its newly launched Supplier Diversity Program.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.12%
Tags
none
-
Rhea-AI Summary

AptarGroup, Inc. (NYSE: ATR) has updated its science-based targets for emissions reduction, aligning with a goal to limit global temperature rise to 1.5° Celsius by 2030. Originally set in 2020 to align with a well below 2°C scenario, the targets have been revised to demonstrate increased ambition. The company aims to reduce absolute Scope 1 and 2 greenhouse gas (GHG) emissions by 82% and Scope 3 emissions by 14% by 2030, using 2019 as the base year. Additionally, Aptar plans to source 100% renewable electricity by 2030. These commitments have been validated by the Science Based Targets initiative (SBTi). Aptar emphasizes its commitment to sustainability through innovative practices.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.17%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.66%
Tags
none
Rhea-AI Summary

AptarGroup, Inc. (NYSE: ATR) announced the appointment of Julie Xing to its Board of Directors. With over 20 years of experience in sectors like pharmaceuticals and medtech, Julie aims to inspire sustainable growth in challenging markets. She previously served as Executive Chair of Mundipharma China and held various leadership roles at Eli Lilly. Aptar's President and CEO, Stephan B. Tanda, emphasized the value of her insights into the pharmaceutical market, particularly in Asia. The company celebrates diversity on its board, with 45% female representation. Julie holds a Ph.D. in Biology from Hong Kong University.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.95%
Tags
management
-
Rhea-AI Summary

AptarGroup, Inc. (NYSE:ATR) reported a net income of $59 million for Q4 2022, a 2% year-over-year increase. While reported sales dipped 2% to $796 million, core sales grew 4%, driven by strong performance in the pharma and beauty segments. Adjusted EBITDA fell 4% to $147 million. For the full year, net income decreased 2% to $239 million, but adjusted earnings per share rose 5% to $3.79. The company completed its 29th consecutive year of increasing dividends, with $99 million returned to shareholders in 2022. Aptar anticipates continued momentum in 2023, focusing on efficiencies and growth in key markets.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.42%
Tags
none
-
Rhea-AI Summary

AptarGroup, Inc. (NYSE: ATR) has once again secured a Platinum rating from EcoVadis, positioning it among the top 1% of over 90,000 companies evaluated across various industries. This recognition highlights Aptar's commitment to sustainability in environmental stewardship, labor rights, ethics, and sustainable procurement.

CEO Stephan B. Tanda stated that this achievement underscores the company's dedication to ethical practices and a circular economy. The EcoVadis rating methodology is based on international sustainability standards, enhancing Aptar’s reputation as a leader in eco-friendly solutions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.04%
Tags
none
Rhea-AI Summary

Aptar Pharma, a leader in drug delivery systems and part of AptarGroup (NYSE: ATR), has launched the APF Futurity nasal spray pump, the first metal-free, multidose nasal spray designed for over-the-counter formulations. This pump, certified as highly recyclable by cyclos-HTP, minimizes recycling challenges and promotes sustainability. Made from polyolefin materials without metal components, APF Futurity supports the global shift towards eco-friendly products. The innovative design, based on proven technology, delivers consistent dosing without compromising performance. The product will be unveiled at Pharmapack 2023 in Paris on February 1-2, 2023.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.46%
Tags
none
-
Rhea-AI Summary

AptarGroup (NYSE: ATR) has declared a quarterly cash dividend of $0.38 per share, payable on February 23, 2023, to stockholders of record as of February 2, 2023. Additionally, a conference call is scheduled for February 17, 2023, at 8:00 a.m. CT to discuss the fourth quarter and year-end results for 2022. The company also announced that the 2023 Annual Meeting of Stockholders will take place virtually on May 3, 2023, at 9:00 a.m. CT, with a record date of March 10, 2023. For further details, visit www.aptar.com.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.16%
Tags
dividends
-
Rhea-AI Summary

AptarGroup, Inc. (NYSE: ATR), based in Crystal Lake, Illinois, announced its quarterly conference call schedule for 2023. Key dates include:

  • Q4 2022 on February 16, 2023 (call on February 17, 2023, at 8:00 a.m. CT)
  • Q1 2023 on April 27, 2023 (call on April 28, 2023, at 8:00 a.m. CT)
  • Q2 2023 on July 27, 2023 (call on July 28, 2023, at 8:00 a.m. CT)
  • Q3 2023 on October 25, 2023 (call on October 26, 2023, at 8:00 a.m. CT)

Press releases will follow after the close of trading on the NYSE.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.8%
Tags
none
Rhea-AI Summary

AptarGroup, Inc. (NYSE: ATR), a leader in drug delivery and consumer product dispensing, will present at the 41st Annual J.P. Morgan Healthcare Conference on January 12, 2023, at 12:45 p.m. EST. Key executives, including President and CEO Stephan Tanda, will be present. The presentation will be accessible on the company's Investors page. Aptar operates globally, providing innovative solutions for various markets, including pharmaceuticals and beauty. The company is headquartered in Crystal Lake, Illinois, employing 13,000 staff across 20 countries.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.88%
Tags
conferences
Aptargroup

NYSE:ATR

ATR Rankings

ATR Stock Data

9.62B
65.26M
0.56%
93.04%
1.14%
Medical Instruments & Supplies
Plastics Products, Nec
Link
United States
CRYSTAL LAKE